Our Team
Meet the Betterhumans team.
We have assembled a stellar scientific advisory board to help guide our effort.
Officer & Directors
James Clement, J.D. LL.M., Ph.D. (student)
President, Director, Co-C.S.O.
James Clement has devoted the last two decades to the science of life extension. He is best known for his Supercentenarian Study, which has received international press (see: Betterhumans Supercentenarian Research Study in the News) in addition to a feature story in the New York Times by Pulitzer Prize–winning writer Amy Harmon. A champion of the transhumanist movement, he is the founder of the Betterhumans non-profit, and is the author of The Switch, published Dec 31, 2019 by Simon and Schuster. Led by a collection of high-profile researchers, the organization focuses on bringing cutting edge scientific discoveries from the lab to the clinic, so that humanity can take advantage of these breakthroughs in a safe and inexpensive manner, as quickly as possible.
Marco Narducci, Ph.D.
Co-C.S.O.
Marco has dedicated the last two decades to the science of performance and resilience, especially in situations where the body is confronted with extreme physiological stressors, environmental adversities, psychological pressures, or after traumatic injuries. He specializes in the research and development of novel-investigational treatments that can bolster and quicken the functional recovery of patients facing progressively deteriorating health conditions or after an acute medical emergency. He is an Adjunct Professor at the University of Ferrara, Italy, Department of Chemical and Pharmaceutical Sciences, and the founder of two innovative biopharmaceutical spinoffs: Unichem Estense, Italy and Impact Science, Japan.
Jim Gibbons
Director
Founder, CEO, and part owner of Seattle Shellfish LL. Industry Advisory Council member of Western Regional Aquaculture Center 2008 to present. Past Board Member of Pacific Coast Shellfish Growers Association. ALCOR member since 2002. Serial entrepreneur. Author and Editor. BA Wittenberg University; MBA American University.
Travis Christofferson, MS.
Director
Travis Christofferson, MS, is the author of Curable and Tripping Over the Truth and received his undergraduate degree in molecular biology from the Honors College at Montana State University and a master’s degree in material engineering and science from the South Dakota School of Mines and Technology. Today he is a full-time science writer and founder of a cancer charity. He lives in South Dakota.
Medical Advisory Board
James P. Watson, M.D.
Dr. James Watson is a Cosmetic, Plastic & Reconstructive Surgery Specialist in Thousand Oaks, CA. He is affiliated with medical facilities such as Los Robles Health System - Los Robles Regional Medical Center and Providence Saint John's Health Center.
Dina Radenkovic, M.D.
Academic doctor at Guy’s and St Thomas’ Hospital, visiting research fellow at the Department of Twins Research and a cardiology researcher at the Massachusetts General Hospital, qualified with dual degree from UCL Medical School in London. Dina is the research lead of the Health and Longevity Optimisation Institute, member of the world’s leading technology entrepreneur network Founders Forum and council representative of the Royal Society of Medicine Digital Health. Her first startup Watch Out Diabetes, in the first cohort of the F-Factor competition, was a successfully implemented digital diabetes in pregnancy prevention programme. Dina is actively publishing in medical literature in the field of longevity and cardiovascular science and is a professional member of the European Society of Cardiology and the European Association for Cardiovascular Imaging.
John A. Sturges, M.D.
Dr. John Sturges is a Family Medicine Specialist in Coeur D Alene, ID and has over 34 years of experience in the medical field. He graduated from Loma Linda School of Medicine medical school in 1986. He is affiliated with Kootenai Health.
Molly Maloof, M.D.
Dr. Molly Maloof is passionate about extending healthspan through her medical practice, personal brand, and educational endeavors. Dr. Molly provides health optimization and personalized medicine to high achieving entrepreneurs, investors, and technology executives in San Francisco and Silicon Valley, as well as award winning Hollywood actors and musicians. She is a lecturer within the Wellness Department of the Medical School at Stanford University where she created a course entitled, "Live Better Longer: Extending Healthspan to Lengthen Lifespan." Since 2012, she has also worked as an advisor or consultant to more than 40 companies in the digital health, consumer health, and biotechnology industries needing help with clinical strategy, product development, clinical research and scientific marketing.
Bruce Tizes, M.D.
Bruce Randolph Tizes, MD, JD, is a graduate of Northwestern University Pritzker School of Law (JD), the Chicago Medical School (MD) and Yale University School of Medicine / School of Public Health (MPH expected May 2021). TIzes served as Lead Editor for the Yale Journal of Health Policy, Law, and Ethics, and has worked in medicine thirty + years. He has been consistently involved with startup and technology ventures since the mid-1980s. During the 2000s Tizes served as principal of hedge fund Galt Capital. Tizes is a Fellow of the Royal Society of Arts (UK) and the Edmund Hillary Fellowship (New Zealand) for global social impact.
Scientific Advisory Board
George Church, Ph.D.
Scientific Advisor
Prof of Genetics, Harvard Medical School, Dir of the Center for Computational Genetics. 1984 Harvard PhD included the first direct genomic sequencing method, molecular multiplexing tags, which lead to automation & software used at Genome Therapeutics Corp. for the first commercial genome sequence -- pathogen, Helicobacter in 1994.
J. Pedro Magalhaes, Ph.D.
Scientific Advisor
Research Fellow in Genetics under George Church at Harvard Medical School. Developed high-throughput approaches for studying ageing, including computational tools and databases. Currently, lecturer in Biological Sciences at University of Liverpool.
Staff Scientists
Megha Agrawal, Ph.D.
Senior Scientist and Director of Operations
Dr. Agrawal received her PhD in biotechnology from Indian Institute of Technology (IIT), Roorkee in India. She is an experienced neuroscientist. She has made fundamental contributions in advancing the field of ischemic stroke, neurodegeneration, and molecular diagnostics. Her current research activities include pilot studies to determine the safety and efficacy of target drugs for improving biomarkers for metabolic-disorders, inflammation, and DNA-damage repair. These studies seek to develop a better understanding of aging and age-related diseases. Dr. Agrawal has published over 100 research papers and technical articles in world’s leading journals and trade magazines. She has edited a number of books published by reputed international publishers. Since 2014, she has been an editor and columnist in biotechnology for Vacuum Technology & Coating magazine.
Monal Sharma, Ph.D.
Senior Scientist for "Biologicals"
Dr. Sharma received her PhD in Biomedical Science from University of Delhi, India and worked at National Institute of Immunology (NII) followed by Postdoctoral Fellowships at Medical School at Washington University in Saint Louis, Missouri, and Norton Thoracic Institute, Saint Joseph Hospital and Medical Centre, Phoenix, AZ. Later Dr. Sharma joined Duke University and worked on Kidney transplant and Immunology. Her current research activities are focused on isolating and characterizing extracellular vesicles along with scaling up their production for use in Betterhumans animal and human studies. With her strong experience with human pluripotent stem cell, she is leading the discovery and translational efforts for preclinical/clinical programs. Dr. Sharma’s research accomplishments have been recognized by numerous scientific organizations including the American Society of Transplantation, International Society of Heart and Lung through awards. She has been the recipient of several travel awards from clinical trials. Dr, Sharma has published more than 30 manuscripts and has been an invited reviewer for a number of international journals.